Nørby B, Nielsen H V, Frimodt-Møller P C
Department of Surgery, Section of Urology, Kolding Hospital, Kolding, Denamark.
BJU Int. 2002 Dec;90(9):853-62. doi: 10.1046/j.1464-410x.2002.03031.x.
To compare the efficacy and frequency of complications of transurethral interstitial laser coagulation (ILC) and transurethral microwave thermotherapy (TUMT) with transurethral resection or incision of the prostate (TURP/TUIP) in patients with symptomatic benign prostatic hyperplasia (BPH).
Forty-eight patients were randomized to undergo ILC, 46 to TUMT and 24 to TURP/TUIP; they were followed for 6 months and the outcome analysed on an intention-to-treat basis.
At 6 months the symptom scores and maximum urinary flow rate (Qmax) had improved significantly in all groups. At 6 months the mean symptom score was 9.2 in both experimental groups and 6.8 in the control group (P > 0.05); the mean Qmax was 20.6 mL/s in the control group, 16.2 in the ILC group (P > 0.05 vs control) and 13.2 in the TUMT group (P < 0.05 vs. the control group). In the TUMT group patients developing urinary retention afterward had a significantly greater increase in Qmax than those who did not. The types of complications in the three groups varied. Urinary tract infection occurred frequently in the experimental groups, especially after ILC, whereas the 'well-known' complications of TURP occurred in the control group. Overall, 36% in the ILC, 54% in the TUMT and 73% in the control group had no complications (retrograde ejaculation excluded) during the first 6 months. One patient in the TUMT group underwent TURP after 3 months, whereas no patients in the ILC or the con-trol group were re-treated for BPH within the first 6 months.
In the short term both ILC and TUMT are reasonable alternatives to standard transurethral surgery for symptomatic BPH, where the reduction of symptoms is the primary goal of treatment. However, both ILC and TUMT were associated with morbidity, although the complication profiles differed from those after TURP/TUIP. Both ILC and TUMT seem advantageous in some patients because of the reduced risk of bleeding and the eliminated risk of TUR syndrome, and because TUMT only requires local anaesthesia. Thus, as neither treatment is better in all aspects, the advantages of one technique over the other must be weighed when deciding how to treat each patient.
比较经尿道间质激光凝固术(ILC)、经尿道微波热疗(TUMT)与经尿道前列腺切除术或前列腺切开术(TURP/TUIP)治疗有症状的良性前列腺增生(BPH)患者的疗效及并发症发生率。
48例患者随机接受ILC治疗,46例接受TUMT治疗,24例接受TURP/TUIP治疗;对他们进行6个月的随访,并基于意向性分析对结果进行分析。
6个月时,所有组的症状评分和最大尿流率(Qmax)均有显著改善。6个月时,两个试验组的平均症状评分为9.2,对照组为6.8(P>0.05);对照组的平均Qmax为20.6 mL/s,ILC组为16.2(与对照组相比P>0.05),TUMT组为13.2(与对照组相比P<0.05)。在TUMT组中,术后发生尿潴留的患者Qmax的增加显著大于未发生尿潴留的患者。三组的并发症类型各不相同。试验组中尿路感染频繁发生,尤其是ILC术后,而对照组发生了TURP的“常见”并发症。总体而言,ILC组36%、TUMT组54%、对照组73%的患者在最初6个月内无并发症(不包括逆行射精)。TUMT组有1例患者在3个月后接受了TURP治疗,而ILC组或对照组在最初6个月内均无患者因BPH再次接受治疗。
在短期内,对于以减轻症状为主要治疗目标的有症状BPH患者,ILC和TUMT都是标准经尿道手术的合理替代方案。然而,ILC和TUMT均与发病率相关,尽管其并发症情况与TURP/TUIP术后不同。ILC和TUMT在某些患者中似乎具有优势,因为出血风险降低且消除了TUR综合征的风险,并且TUMT仅需要局部麻醉。因此,由于两种治疗方法在所有方面都并非更好,在决定如何治疗每位患者时,必须权衡一种技术相对于另一种技术的优势。